Hjem › Tykktarmskreft › Illinois › Chicago
Kliniske studier for Tykktarmskreft i Chicago, IL
14 studier for Tykktarmskreft søker deltakere på steder i og rundt Chicago (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Family Communications After Genetic Testing
RekruttererFrivillige helsepersonell ønskes velkommen
- Advocate Illinois Masonic Medical Center, Chicago
PRE-ISPY Phase I/II Oncology Platform Program
RekruttererFase 1/2
- The University of Chicago Medicine Comprehensive Cancer Center, Chicago
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RekruttererFase 3
- Illinois Cancer Specialists, Chicago
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
RekruttererFase 3
- University of Illinois Cancer Center, Chicago
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Rekrutterer
- John H Stroger Jr Hospital of Cook County, Chicago
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
RekruttererFase 2/3
- Mount Sinai Hospital Medical Center, Chicago
- Northwestern University, Chicago
- John H Stroger Jr Hospital of Cook County, Chicago
- og 5 flere
BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion
RekruttererFase 1/2
- Northwestern University, Chicago
Shield Post-Approval Study Protocol
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- GI Solutions of Illinois, Chicago
- GI Solutions of Illinois, Chicago
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
RekruttererFase 1
- Xencor Investigative Site, Chicago
- Xencor Investigative Site, Chicago
Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3
RekruttererFase 2
- City of Hope at Illinois Chicago Downtown, Chicago
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RekruttererFase 1/2
- University of Chicago, Chicago
Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Section of Gastroenterology, Hepatology, and Nutrition, Department of Medicine University of Chicago Medicine, Chicago
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
RekruttererFase 3
- GSK Investigational Site, Chicago
- GSK Investigational Site, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Chicago
Tykktarmskreft-studier i andre byer
- Boston, MA22 studier
- New York City, NY22 studier
- Houston, TX20 studier
- Nashville, TN16 studier
- Los Angeles, CA16 studier
- Arlington, VA15 studier
- St. Louis, MO15 studier
- Baldwin Park, CA14 studier
- San Antonio, TX14 studier
- Tampa, FL13 studier
- Baltimore, MD13 studier
- Washington, DC12 studier
Andre studier i Chicago
- Ikke-småcellet lungekreft61 studier
- Brystkreft58 studier
- Kreft (alle typer)51 studier
- Metastatisk kreft45 studier
- Prostatakreft45 studier
- Fedme41 studier
- Lungekreft41 studier
- Eggstokkreft36 studier
- Slag34 studier
- Kolorektal kreft33 studier
- Hjertesvikt31 studier
- Overvekt28 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.